A meta-analysis that included a total of over 1.4 million subjects found a lower risk of dying from cardiovascular disease in patients using metformin compared to those treated with another class of diabetes drugs known as sulfonylureas. The review, which updates two previous analyses, was...
The information provided on this site is for informational purposes only and is not intended as a substitute for advice from your physician or other health care professional or any information contained on or in any product label or packaging. You should not use the information on this site for diagnosis or treatment of any health problem or for prescription of any medication or other treatment. You should consult with a healthcare professional before starting any diet, exercise or supplementation program, before taking any medication, or if you have or suspect you might have a health problem. You should not stop taking any medication without first consulting your physician.